↓ Skip to main content

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy

Overview of attention for article published in Journal of Hematology & Oncology, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
2 news outlets
twitter
1 X user
patent
1 patent

Citations

dimensions_citation
228 Dimensions

Readers on

mendeley
185 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
Published in
Journal of Hematology & Oncology, March 2019
DOI 10.1186/s13045-019-0718-5
Pubmed ID
Authors

Shuang Qin, Anping Li, Ming Yi, Shengnan Yu, Mingsheng Zhang, Kongming Wu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 185 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 185 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 12%
Student > Ph. D. Student 19 10%
Student > Bachelor 19 10%
Student > Doctoral Student 11 6%
Researcher 11 6%
Other 22 12%
Unknown 80 43%
Readers by discipline Count As %
Medicine and Dentistry 26 14%
Biochemistry, Genetics and Molecular Biology 24 13%
Pharmacology, Toxicology and Pharmaceutical Science 18 10%
Chemistry 10 5%
Agricultural and Biological Sciences 9 5%
Other 15 8%
Unknown 83 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2021.
All research outputs
#1,887,503
of 25,837,817 outputs
Outputs from Journal of Hematology & Oncology
#140
of 1,307 outputs
Outputs of similar age
#42,182
of 367,522 outputs
Outputs of similar age from Journal of Hematology & Oncology
#4
of 28 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,307 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,522 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.